The $100 billion private investment firm Ardian announced that it acquired a 50% ownership stake in ANGUS Chemical Company from Golden Gate Capital in a deal valued at $2.25 billion.
Golden Gate’s stake that was initially acquired in February 2015 from The Dow Chemical Company, and it will retain its 50% stake in ANGUS, an Illinois-headquartered company that makes solutions that are widely used in applications to help combat the spread of COVID-19, including high-alcohol hand sanitizer gels, diagnostic kits, antibody treatments and vaccines.
Officials said that over the . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
